Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Cordgenics, LLC
BPGbio
Taproot Health
Massachusetts General Hospital
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)